Android Apple

PGIM Jennison Health Sciences Fund Sold AbbVie (ABBV) in Q2. Here's Why

By Yahoo! Finance   |   2 months ago
PGIM Jennison Health Sciences Fund Sold AbbVie (ABBV) in Q2. Here's Why

The PGIM Jennison Health Sciences Fund's Q2 2024 investor letter highlighted its performance and top holdings, including AbbVie Inc. (NYSE:ABBV), a pharmaceutical company. The fund underperformed slightly, with notable contributions from sectors like pharmaceuticals and MedTech.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.